Results 101 to 110 of about 38,752 (185)

Decoding antibody response to MERS-CoV in wild dromedary camels. [PDF]

Proc Natl Acad Sci U S A
Idoudi F, Wang R, Tian L, Yang Z, Chik KK, Chen P, Benabderrazek R, Fu L, Tan R, Dhaouadi S, Benlasfar Z, Somia M, Zhang Q, Shi X, Fuk-Woo Chan J, Yuen KY, Wang X, Bouhaouala-Zahar B, Zhang L.   +18 more
europepmc   +1 more source

RASP: rapid antibody functional screening by pentavalent phage display. [PDF]

MAbs
Kaur M, Dubey A, Chandran K.
europepmc   +1 more source

One-step cleavage and purification: a bifunctional IdeS-Protein A fusion protein for on-column generation of antibody fragments. [PDF]

MAbs
Zhang T, Liao H, Teng CB, Wang C.
europepmc   +1 more source

Integrated platform for EV separation and controlled release based on gelatin microspheres for diabetic wound treatment. [PDF]

Regen Biomater
Zhang Y, Huang Q, Meng H, Chen J, Hao Y, Liu X, Xu Y, Ma L, Xu Z, Ma K, Hu W, Pan X, Fu X, Zhang C.   +13 more
europepmc   +1 more source

Development and Preliminary Evaluation of an OMP16-Targeting Trivalent Nanobody-HRP-Based cELISA for Serological Detection of Bovine Brucellosis. [PDF]

Animals (Basel)
Wudong G, Lu Q, Zhai Y, Yuan Y, Liu X, Yang Y, Zhang L, Jin Y, Zhou D, Wang A.   +9 more
europepmc   +1 more source

Concept: VHH i-docs

Concept for i-docs that construct (filmic) pathways through the repository.
openaire   +1 more source

Llama VHH as immunotherapeutics in Alzheimer's disease

, 2013
Alzheimer's Disease (AD) is the most common form of dementia among elderly in the Western world. AD is a devastating neurodegenerative disease where patients starting with episodic memory problems end up completely bedridden and care dependent. At present there is no real therapy stopping or reversing AD progression.
openaire   +2 more sources

A yeast synthetic biotic platform for delivery of therapeutic nanobodies to ameliorate gastrointestinal inflammation. [PDF]

Dis Model Mech
Palou R, van der Sloot AM, Fiebig AA, Zangara MT, Sangwan N, Sánchez-Osuna M, Ilyas B, Zubyk H, Cook M, Wright GD, Coombes BK, Tyers M.   +11 more
europepmc   +1 more source

Development of Bispecific Antibody Targeting Human IL-17A and IL-6. [PDF]

Antibodies (Basel)
Pamuła B, Banach M, Mikońska M, Korytkowska K, Lacek K, Śniadała O, Marczak M, Flis K, Sowińska A, Kołakowski D, Pieczykolan J, Zygmunt B, Wieczorek M, Abramczyk O.   +13 more
europepmc   +1 more source

Nanobodies in biomedicine: from molecular characteristics to fabrication and clinical translation. [PDF]

Mil Med Res
Cao CK, Xu XY, Liang F, Yao M, Chen YY, Li XK, Su ZJ.   +6 more
europepmc   +1 more source